iPR Pharmaceuticals submitted a proposal to the AstraZeneca Sustainability Fund to finance a project that aimed to reduce the carbon footprint by approximately 40 percent.
“Federal funding has been essential to rebuilding Puerto Rico’s infrastructure, supporting its health care system and ensuring educational opportunities for its residents. Any cuts to these resources would directly affect the island’s most vulnerable communities and jeopardize the progress made in recent years.”
— Sergio M. Marxuach, policy director, Center for a New Economy